Loading clinical trials...

COMPLETEDPhase 1/2NCT00395629

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Brief Summary: This study was designed to explore a safe dose and characterize the preliminary safety and efficacy of ICL670 in adult patients with previously documented history of homozygous C282Y.

Lead sponsor: Novartis Pharmaceuticals•9 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not Recruiting

Ethnic Differences in Iron Absorption (FeGenes)

NCT04198545 · Anemia, Iron Deficiency, Iron Overload

Not Yet RecruitingPhase 1/2

A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

NCT07371793 · Hereditary Hemochromatosis

COMPLETEDPhase 2

PTG-300 in Subjects With Hereditary Hemochromatosis

NCT04202965 · Hereditary Hemochromatosis

COMPLETED

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

NCT04423237 · Iron Overload

COMPLETEDNA

Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia

NCT05326503 · Thalassemia, Iron Overload

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 30, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment49

Start dateAug 2006

Last updatedMay 30, 2011

Condition

Iron Overload Hereditary Hemochromatosis

Locations shown

UC Irvine/Long Beach

Long Beach, California

University of Connecticut Health Center

Farmington, Connecticut

Henry Ford Health System

Detroit, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions